• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Dicerna Pharmaceuticals Inc

+ Add to Watchlist

DRNA:US

14.0600 USD 0.0400 0.29%

As of 20:10:00 ET on 08/22/2014.

Snapshot for Dicerna Pharmaceuticals Inc (DRNA)

Open: 13.9600 Day's Range: 13.5500 - 14.4000 Volume: 106,643
Previous Close: 14.0200 52wk Range: 13.3300 - 46.0000 1-Yr Rtn: -

Stock Chart for DRNA

No chart data available.
  • DRNA:US 14.0600
  • 1D
  • 1M
  • 1Y
14.0200
Interactive DRNA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DRNA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -2.4150
Est. PEG Ratio -
Market Cap (M USD) 249.83
Shares Outstanding (M) 17.77
30 Day Average Volume 211,915
Price/Book (mrq) 2.0779
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DRNA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DRNA

Dicerna Pharmaceuticals, Inc. provides biopharmaceutical products. The Company discovers and develops ribonucleic acid for the treatment of liver diseases and cancer.

Douglas M Fambrough IIIPresident/CEO/Co-FounderJames E Dentzer "Jim"Chief Financial Officer
James B WeissmanChief Business OfficerPankaj BhargavaChief Medical Officer
More Company Profile & Key Executives for DRNA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil